scholarly journals Falling Through the Cracks: The Need to Include Acute Pancreatitis in Risk Assessment Models for Acute Deep Venous Thrombosis

Cureus ◽  
2020 ◽  
Author(s):  
James Kamau ◽  
Elisabeth Paul ◽  
Mathai Chalunkal ◽  
Richard Snyder ◽  
Douglas S Corwin
Keyword(s):  
Risk Assessment ◽  
Acute Pancreatitis ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Risk Assessment Models

scholarly journals Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms

2018 ◽  
Vol 24 (9_suppl) ◽  
pp. 127S-135S ◽  
Author(s):  
Xiaolan Chen ◽  
Lei Pan ◽  
Hui Deng ◽  
Jingyuan Zhang ◽  
Xinjie Tong ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Blood Platelets ◽  
Predictive Ability ◽  
Hospitalized Patients ◽  
Surgical Patients ◽  
Receiver Operating Curve ◽  
Lower Specificity ◽  
Higher Sensitivity

The current venous thromboembolism (VTE) guidelines recommend all patients to be assessed for the risk of VTE using risk assessment models (RAMs). The study was to evaluate the performance of the Caprini and Padua RAMs among Chinese hospitalized patients. We reviewed data from 189 patients with deep venous thrombosis (DVT) and 201 non-DVT patients. Deep venous thrombosis risk factors were obtained from all patients. The sensitivity and specificity of the Caprini and Padua scores for all patients were calculated. The receiver operating curve (ROC) and the area under the ROC curve (AUC) were used to evaluate the performance of each score. We documented that age, acute infection, prothrombin time (PT), D-dimer, erythrocyte sedimentation rate, blood platelets, and anticoagulation were significantly associated with the occurrence of DVT ( P < .05). These results were true for all medical and surgical patients group (G1), as well as the analysis of medical versus surgical patients (G2). Finally, analysis of the scores in patients with and without cancer was also done (G3). The Caprini has a higher sensitivity but a lower specificity than the Padua ( P < .05). Caprini has a better predictive ability for the first 2 groups ( P < .05). We found Caprini and Padua scores have a similar predictive value for patients with cancer ( P > .05), while Caprini has a higher predictive ability for no cancer patients in G3 than Padua ( P < .05). For Chinese hospitalized patients, Caprini has a higher sensitivity but a lower specificity than Padua. Overall, Caprini RAM has a better predictive ability than Padua RAM.

Mo1224 - Epidemiology of Deep Venous Thrombosis after first Ever Episode of Acute Pancreatitis: A Population-Based National Study

2018 ◽  
Vol 154 (6) ◽  
pp. S-709-S-710
Author(s):  
Sonali Khurana ◽  
Emad Mansoor ◽  
Daniel Karb ◽  
Peter Lee ◽  
Brooke Glessing ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Population Based ◽  
National Study

scholarly journals Acute pancreatitis: a complication associated with rheolytic mechanical thrombectomy of deep venous thrombosis

2006 ◽  
Vol 44 (5) ◽  
pp. 1110-1113 ◽  
Author(s):  
Kenneth T. Piercy ◽  
Juan Ayerdi ◽  
Randolph L. Geary ◽  
Kimberley J. Hansen ◽  
Matthew S. Edwards
Keyword(s):  
Acute Pancreatitis ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Mechanical Thrombectomy

scholarly journals Validation of risk assessment models for venous thrombosis in hospitalized medical patients

2019 ◽  
Vol 3 (2) ◽  
pp. 217-225 ◽  
Author(s):  
Michelle R. R. Cobben ◽  
Banne Nemeth ◽  
Willem M. Lijfering ◽  
Suzanne C. Cannegieter
Keyword(s):  
Risk Assessment ◽  
Venous Thrombosis ◽  
Medical Patients ◽  
Risk Assessment Models

Tu1596 PRESENCE OF NECROSIS INCREASES THE ODDS OF DEEP VENOUS THROMBOSIS AND/OR PULMONARY EMBOLISM IN ACUTE PANCREATITIS

2020 ◽  
Vol 158 (6) ◽  
pp. S-1131
Author(s):  
Abhishek Bhurwal ◽  
Lauren Pioppo ◽  
Mishal Reja ◽  
Haroon M. Shahid ◽  
Avik Sarkar ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Acute Pancreatitis ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis

scholarly journals Virtual risk assessment pathway for deep venous thrombosis: a preliminary model

2020 ◽  
pp. postgradmedj-2020-138837
Author(s):  
Karthikeyan P Iyengar ◽  
Vijay Kumar Jain ◽  
Manjusha Soni ◽  
Zuned Hakim
Keyword(s):  
Risk Assessment ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Management Plan ◽  
Face To Face ◽  
Telemedicine Technology ◽  
Preliminary Model ◽  
Patient Consultation ◽  
Specialist Nurses ◽  
Novel Coronavirus

BackgroundCOVID-19 has necessitated the reduction in conventional face-to-face patient consultation to reduce the risk of novel coronavirus SARS-CoV-2 transmission. Traditional pathways to risk assess for deep venous thrombosis (DVT) would involve face-to-face assessment to formulate an appropriate management plan following an initial presentation usually in secondary care or in-hospital settings. Appropriate antithrombotic measures can prevent complication of DVT such as pulmonary embolism with prompt early diagnosis and treatment.MethodsThis observational, pilot study evaluates the possibility of combining telemedicine technology and a virtual examination pathway for remote triage and assessment of patients with suspected DVT.ResultsPiloting and development of a virtual risk assessment pathway for DVT involves various challenges and multidisciplinary co-ordination.ConclusionAdvances in telecommunication technology can enable clinicians, specialist nurses and hospital departments to develop a virtual examination pathway for remote triage and assessment of patients with suspected DVT. This pathway is not a replacement for conventional ‘face-to-face’ evaluation, but we believe the template can be explored and refined to act as a blueprint for future applications even when the pandemic has stabilised.

Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis

2013 ◽  
Vol 28 (1_suppl) ◽  
pp. 34-38 ◽  
Author(s):  
M Jørgensenø ◽  
R Broholm ◽  
N Bækgaard
Keyword(s):  
Risk Assessment ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Antiphospholipid Syndrome ◽  
Individual Risk ◽  
Anticoagulation Treatment ◽  
Catheter Directed Thrombolysis ◽  
Long Time ◽  
Individual Risk Assessment ◽  
In Pregnancy

Objective: To assess the safety and efficacy of low-molecular-weight heparin (LMWH) in pregnancy and puerperium in women with previous acute iliofemoral deep venous thrombosis (DVT) treated with catheter-directed thrombolysis (CDT). Materials and methods: Consecutive patients treated for acute iliofemoral DVT using CDT between June 1999 and June 2009 were followed yearly by colour duplex ultrasound scanning. A subgroup of these patients who became pregnant during the follow-up period, three months to 10 years after CDT, was included in the present study. During pregnancy, thromboprophylaxis using LMWH was prescribed according to individual risk assessment, and the women were regularly assessed for adverse events. Women on warfarin had this treatment discontinued before the sixth week of pregnancy in order to prevent potential teratogenic adverse effects. Administration of LMWH was started at international normalized ratio ≤<2.0, and continued during pregnancy, delivery and puerperium. Postnatal, the anticoagulation treatment was converted back to warfarin and LMWH discontinued after a bridging period. Women, who, prior to pregnancy, had discontinued anticoagulation treatment after CDT, were prescribed anticoagulation treatment using LMWH as early in pregnancy as practical. LMWH was continued during pregnancy, delivery and for six weeks postpartum. All women were prescribed graduated compression stockings. Results: A total of 33 women completed 45 pregnancies, 44 singletons and 1 gemelli. In 24 (53%) of the cases, the mother had been treated with adjunctive stenting immediately following the CDT. In nine (21%) of the pregnancies, the mother had been on long-time anticoagulation treatment using warfarin prior to conception due to permanent severe risk factors. Thrombophilia was demonstrated in 31 (69%) of the pregnancies, and in 29 (64%) of the patients, the previous DVT was oestrogen-related. Thromboprophylaxis using tinzaparin was given in 41 (91%) and using dalteparin in four (9%) of the pregnancies. Doses of LMWH during pregnancy were adjusted according to risk assessment. One pregnancy was terminated by induced delivery at week 22 due to fetal malformations, and two of the pregnancies (4%) were complicated by intrauterine fetal death, one in week 39 due to severe fetal infection and one in week 23 due to intrauterine fetal growth restriction caused by severe antiphospholipid syndrome. All but one of the pregnancies was carried out without recurrence of DVT or maternal pulmonary embolism and the mother remained having patent deep veins postnatal. The mother with the antiphospholipid syndrome had a recurrent DVT complicated by iliac stent occlusion. This mother was prior to pregnancy on long-time treatment using warfarin. During pregnancy, she was erroneously treated with LMWH in standard prophylaxis doses instead of therapeutic doses and without adding aspirin. Conclusions: After CDT for acute iliofemoral DVT including adjunctive stenting, pregnancy can be carried out almost uneventful even in women at high risk of thromboembolism. Thromboprophylaxis during pregnancy using LMWH in a dosage adjusted to individual risk assessment, is essential.

Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing

2002 ◽  
Vol 112 (3) ◽  
pp. 198-203 ◽  
Author(s):  
Jacques Cornuz ◽  
William A Ghali ◽  
Daniel Hayoz ◽  
Rebecca Stoianov ◽  
Michèle Depairon ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Assessment Methods ◽  
Clinical Prediction ◽  
D Dimer
Sign in / Sign up

Export Citation Format

Share Document